Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
MindMaze Therapeutics Holding S.A.

MindMaze Therapeutics Holding S.A. (MMTX.SW) Stock Overview

Explore MindMaze Therapeutics Holding S.A.’s financial performance, market position, analyst ratings, and future outlook.

MMTX.SW●SIX
HealthcareBiotechnology
CHF0.20
CHF0.02(10.48%)
Swiss Market opens in 11h 11m

MindMaze Therapeutics Holding S.A. (MMTX.SW)

Meyka AI Score

Z

Key Financials

Market Cap35.9M
P/E RatioN/A
EPS (TTM)$-0.48
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.05
3 Months$0.00
1 Year Target$0.00

MMTX.SW Stock Analysis & Investment Overview (SIX)

Our AI-powered analysis of MindMaze Therapeutics Holding S.A. (SIX: MMTX.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, MindMaze Therapeutics Holding S.A.'s SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MMTX.SW on the SIX shows an RSI of 54.24, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the SIX listing.

Key metrics behind MindMaze Therapeutics Holding S.A.'s SIX-traded stock include a P/E ratio of N/A and a market capitalization of 35.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MMTX.SW on the SIX.

Price Performance (SIX: MMTX.SW)

1-Day Change
-0.66%
5-Day Change
1.79%
1-Month Change
41.13%
3-Month Change
-46.66%
6-Month Change
-78.13%
Year-to-Date (YTD) Change
-85.32%
1-Year Change
-78.54%
3-Year Change
-78.54%
5-Year Change
-78.54%
All-Time (Max) Change
-78.54%

Contact Information

https://mindmazetherapeutics.com
41 21 552 08 01
Chemin de Roseneck 5, Geneva, GE, 1006

Company Facts

100 Employees
IPO DateDec 15, 2025
CountryCH
Actively Trading

Frequently Asked Questions